A phase 2, open-label, randomized, 2-way crossover, clinical trial to compare the pharmacokinetics of 2 formulations of 'intended commercial product' Technosphere insulin inhalation powder and to determine the bioavailability of a 30 unit cartridge of `intended commercial product' Technosphere insulin inhalation powder versus a 10 unit subcutaneous injection of insulin lispro in subjects with type 1 diabetes mellitus
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2014
At a glance
- Drugs Insulin; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 27 Jun 2010 Results reported at Amercian Diabetes Association (ADA) meeting, according to a MannKind Corporation media release.
- 17 May 2008 New trial record.